Bevacizumab-Induced Hypertension as a Potential Physiological Clinical Biomarker for Improved Outcomes in Patients With Recurrent Glioblastoma Multiforme: A Systematic Review

With the advancement in medicine leading to the discovery of anti-vascular endothelial growth factor drugs, numerous oncologists are now commonly using antiangiogenic medications to improve outcomes and attain disease control. Thus, the significance of prognostic and predictive indicators in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Kokab Irfan, Ramesh, Prasana, Kanagalingam, Suthasenthuran, Zargham Ul Haq, FNU, Victory Srinivasan, Nishok, Khan, Aujala Irfan, Mashat, Ghadi D, Hazique, Mohammad, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576252/
https://www.ncbi.nlm.nih.gov/pubmed/36277543
http://dx.doi.org/10.7759/cureus.29269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576252/
https://www.ncbi.nlm.nih.gov/pubmed/36277543
http://dx.doi.org/10.7759/cureus.29269

Ejemplares similares